Vimarsana
Biggest News Aggregation in the World

Page 22 - Grant Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Grant Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Grant Date Today - Breaking & Trending Today

Dialight : Proposed Rules of the Dialight plc 2023 Restricted Share Plan to be read with Notice of Annual General Meeting 2023 - Vimarsana News

Dialight : Proposed Rules of the Dialight plc 2023 Restricted Share Plan to be read with Notice of Annual General Meeting 2023

DIALIGHT PLC RULES OF THE DIALIGHT PLC 2023 RESTRICTED SHARE PLAN Approved by shareholders of the Company in general... | April 12, 2023

Hill & Smith : 2023 Notice of Annual General Meeting - Appendix (LTIP Rules) - Vimarsana News

Hill & Smith : 2023 Notice of Annual General Meeting - Appendix (LTIP Rules)

RULES OF THE HILL & SMITH 2023 LONG TERM INCENTIVE PLAN Approved by the shareholders of Hill & Smith plc on [ ] May 2023 ... | April 12, 2023

Investegate |abrdn PLC Announcements | abrdn PLC: Notification of Interests of Executive Directors - Vimarsana News

Investegate |abrdn PLC Announcements | abrdn PLC: Notification of Interests of Executive Directors

Investegate announcements from abrdn PLC, Notification of Interests of Executive Directors

Synthomer : Performance Share Plan rules showing the proposed change detailed in the Notice of the 2023 Annual General Meeting - Vimarsana News

Synthomer : Performance Share Plan rules showing the proposed change detailed in the Notice of the 2023 Annual General Meeting

Synthomer plc SYNTHOMER PERFORMANCE SHARE PLAN Approved by shareholders of the Company on 29 June 2011 Adopted by the... | April 12, 2023

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted...